Brian Goodman

Co- Founder and Board Director, ReNAgade Therapeutics

Partner at MPM Capital

Boston, Massachusetts

About

Male

Brian Goodman is the Partner of MPM BioImpact. He previously worked at Evelo Biosciences as a Head of Technology and Innovation. Brian Goodman attended Brandeis University.

Experience

MPM Capital

Partner · 2022 – present

View →

31Boston, Massachusetts, United StatesBiotechnology · Health Care

Member Board of Directors · Antiva Biosciences
2023 – present
Co-Founder and CBO · Aktis Oncology
2022 – present
Member Board Of Directors · Orna Therapeutics
2021 – present
Co- Founder and Board Director · ReNAgade Therapeutics
2021 – present

Education

Harvard Medical School · PhD, Biochemistry
2008 – 2013
Brandeis University · BS and BA, Biochemistry and Economics
2004 – 2008

Headlines from Google News. Social posts load from the platform only when you open a tab.

Aktis Oncology Announces $72M Series A Financing To Advance Breakthrough Radiopharmaceuticals To Treat Solid Tumors
PR Newswire · Mar 18
New Company Debuts with $72 Million to Advance a Novel Class of Targeted Radiopharmaceuticals
BioSpace · Mar 18
Aktis bags $72M in Novartis, BMS-backed series A to unlock power of radiopharmaceuticals
Fierce Biotech · Mar 18
Novartis, Bristol Myers join $72M funding for startup’s cancer radiotherapy R&D
MedCity News · Mar 18

People at MPM Capital

Elizabeth Stoner

Executive Partner

Ansbert Gadicke

Managing Director and Co-Founder

Data from: crunchbase